Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-19

FDA Approved: ALISKIREN — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for aliskiren (Tekturna) submitted by Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tekturna (aliskiren)

Snippet

SUPPL AP for ALISKIREN (ALISKIREN)